Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05
Osteoporosis International · 2024
DOI: 10.1007/s00198-024-07260-9 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Osteoporosis International, 2024. Verfasst von Yasuhiro Takeuchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Toranomon Hospital Endocrine Center, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan. takeuchi-tky@toranomon.gr.jp. Hauptthemen laut MEDLINE: Alendronate, Bone Density Conservation Agents, Teriparatide, Osteoporotic Fractures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Public Health Research Foundation, Asahi Kasei Pharma Corporation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Toranomon Hospital Endocrine Center, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan. takeuchi-tky@toranomon.gr.jp.
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan. takeuchi-tky@toranomon.gr.jp.
- Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Public Health Research Foundation, Shinjuku-Ku, Tokyo, Japan.
- Department of Rehabilitation, Sanin Rosai Hospital, Yonago, Tottori, Japan.
- Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Förderung
- Public Health Research Foundation
- Asahi Kasei Pharma Corporation
Zitieren
APA
Takeuchi, Y., Tanaka, S., Kuroda, T., Hagino, H., Mori, S., & Soen, S. (2024). Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05. Osteoporosis International. https://doi.org/10.1007/s00198-024-07260-9
Vancouver
Takeuchi Y, Tanaka S, Kuroda T, Hagino H, Mori S, Soen S. Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05. Osteoporosis International. 2024. doi:10.1007/s00198-024-07260-9
BibTeX
@article{Takeuchi2024,
author = {Takeuchi, Yasuhiro and Tanaka, Shiro and Kuroda, Tatsuhiko and Hagino, Hiroshi and Mori, Satoshi and Soen, Satoshi},
title = {Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05},
journal = {Osteoporosis International},
year = {2024},
doi = {10.1007/s00198-024-07260-9}
}
EUVIMED